Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:1124 (13 November), doi:10.1136/bmj.329.7475.1124-b
London Lynn Eaton
Doctors need to take the risk of psychiatric side effects from prescription drugs far more seriously than they currently do—and to be prepared to listen to patients who report adverse reactions to treatment.
That was the message from a one day conference held in London last week by the charity the Adverse Psychiatric Reactions Information Link (APRIL). The organisation was set up in 1998 by Millie Kieve, whose daughter, Karen, died after falling from a window. Mrs Kieve is convinced that it was her daughter’s reactions to various drugs—including sulfasalazine for Crohn’s disease and, six years later, co-cyprindiol (Diannette) for hormonal problems—that were to blame for the breakdowns and attacks of psychosis that preceded her death.
Many people in the conference audience had experienced adverse psychiatric reactions themselves or cared for someone who had. They reported negative responses from doctors, who dismissed their concerns as "imagined" and
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses